FDA-Drug2026-09-30Class IIPROCESSING DEFECT
Clear Eyes Redness Relief eye drops recalled for lack of sterility assurance
What this means
Clear Eyes Redness Relief eye drops distributed nationwide may not meet sterility standards required for products applied directly to the eye. The FDA has recalled specific lot numbers manufactured between July and November 2027. No injuries have been reported, but eye drops that are not sterile can pose a risk of infection.
- Check your Clear Eyes Redness Relief bottle for a lot number matching RL25G02–G04, RL25H02–H04, RL25K01–K04, RL25M01–M04, or RL25N01–N02, N04 (expiration dates July–November 2027).
- Stop using the product if your lot number is listed.
- Speak with your pharmacist or doctor about safe alternatives.
- Do not pour the product down the drain; ask your pharmacy about proper disposal.
The agency's original wording
Hazard
Lack of Assurance of Sterility
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA.
Affected count
2,356,248 bottles
Manufactured in
660 White Plains Rd Ste 250, Tarrytown, NY, United States
Products
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0870-2026More Prestige Consumer Healthcare recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.